CBER
-
FDA swiftly reverses RTF decision on Moderna flu shot candidate
The regulator is allowing the pharma giant’s revised biologics licensed application to proceed to review.
-
RTF flu vaccine letter heard around the world
The FDA issued an extremely rare refuse-to-file letter related to Moderna’s new mRNA flu vaccine.
-
FDA issues warning letters to four companies for sale of HIV self-collection blood tests
The federal regulator contends the four biologics firms lack appropriate testing and marketing authorization.